BioCentury
ARTICLE | Clinical News

Atrisorb tissue regeneration barrier containing doxycycline: ATRX will begin a 120-patient pivotal trial

July 13, 1998 7:00 AM UTC

Atrix Laboratories Inc. (ATRX), Fort Collins, Colo. Product: Atrisorb tissue regeneration barrier containing doxycycline Indication: Treat periodontal disease Status: ATRX will begin a 120-patient pi...